The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. MabThera/Rituxan was produced by Roche.
Also on the agenda is a closer look at the AUGMENT trial of Revlimid with Roche’s Rituxan (rituximab) in relapsed/refractory indolent lymphoma.
As expected, biosimilar competition to two of its top products – MabThera and Herceptin – weighed heavy on Roche in the third quarter in Europe. ... 9% overall thanks to gains in the US, where it is sold as Rituxan, as well as international markets,
Roche is in need of a new set of innovative products, as its older generation of blockbusters, Avastin, Herceptin and MabThera/Rituxan come under competition from biosimilars.
Herceptin, MabThera and Humira – but Warwick Smith says the new plan puts this target in jeopardy.
Roche has seen revenues from blockbuster MabThera/Rituxan slashed in half in Europe thanks to growing biosimilar competition in the second quarter.
[ Previous 5 results ] 4 5 6 7 8 9 10 11 12 13 [ Next 5 results ]
Kardex is a global industry partner for intralogistics solutions and a leading supplier of automated storage solutions and material handling...